Lymphocytes in cystic fibrosis lung disease: a tale of two immunities
- PMID: 15008966
- PMCID: PMC1808975
- DOI: 10.1111/j.1365-2249.2003.02389.x
Lymphocytes in cystic fibrosis lung disease: a tale of two immunities
Comment on
-
Dysregulation of IL-2 and IL-8 production in circulating T lymphocytes from young cystic fibrosis patients.Clin Exp Immunol. 2004 Mar;135(3):528-34. doi: 10.1111/j.1365-2249.2003.02385.x. Clin Exp Immunol. 2004. PMID: 15008989 Free PMC article.
Similar articles
-
The genesis of cystic fibrosis lung disease.J Clin Invest. 1999 Feb;103(3):309-12. doi: 10.1172/JCI6222. J Clin Invest. 1999. PMID: 9927490 Free PMC article. Review. No abstract available.
-
Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis.Mediators Inflamm. 2018 May 2;2018:7280747. doi: 10.1155/2018/7280747. eCollection 2018. Mediators Inflamm. 2018. PMID: 29853791 Free PMC article. No abstract available.
-
New Developments in Cystic Fibrosis Airway Inflammation.Mediators Inflamm. 2015;2015:769425. doi: 10.1155/2015/769425. Epub 2015 Jun 29. Mediators Inflamm. 2015. PMID: 26221065 Free PMC article. No abstract available.
-
Innate immunity in cystic fibrosis lung disease.J Cyst Fibros. 2012 Sep;11(5):363-82. doi: 10.1016/j.jcf.2012.07.003. Epub 2012 Aug 20. J Cyst Fibros. 2012. PMID: 22917571 Review.
-
Innate Immunity in Cystic Fibrosis: Novel Pieces of the Puzzle.J Innate Immun. 2016;8(6):529-530. doi: 10.1159/000448285. Epub 2016 Aug 19. J Innate Immun. 2016. PMID: 27537521 Free PMC article. No abstract available.
Cited by
-
Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA.PLoS One. 2010 Jun 8;5(6):e11004. doi: 10.1371/journal.pone.0011004. PLoS One. 2010. PMID: 20543983 Free PMC article.
-
Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes.Respir Res. 2006 Jul 30;7(1):104. doi: 10.1186/1465-9921-7-104. Respir Res. 2006. PMID: 16875506 Free PMC article.
References
-
- Donaldson SH, Boucher RC. Update on pathogenesis of cystic fibrosis lung disease. Curr Opin Pulm Med. 2003;9:486–91. - PubMed
-
- Xu Y, Clark JC, Aronow BJ, et al. Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency. J Biol Chem. 2003;278:7674–82. - PubMed
-
- Merlo CA, Boyle MP. Modifier genes in cystic fibrosis lung disease. J Lab Clin Med. 2003;141:237–41. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical